What is pathophysiology of Urticaria?

['Ascolta questa pagina']

Qual è la fisiopatologia de l'urticaria?

L'urticaria, comunement cognossuda cuma urticaria, l"è una condizion de la pell caratterizada de l'aparizion de bruf de color ross, alzà e pruriginus in su la pell.

La fisiopatologia de l'urticaria la coinvolge el rilasciament de istamina e olter mediator inflamatori dei mastocit, qe i è cellule immunitarie qe se troeuven ind la pel e olter tessud.

Ind l'urticaria acuta, el rilasciament de istamina e olter mediator l"è scatenad de una reazion allergica a un allergen specifeg, comè el mangiar, la medesina o la puntura de insett.

Chesto al fa che i mastocit se degranulen, liberand istamina e olter mediadur che fan diventar i vas sanguigni permeabili, condusend a la formaziun de rued.

Ind l'urticaria cronica, la causa l"è despess scunusüda, ma se pensa che la sia ligada a un mecanism autoimun.

In chest cas, el corp el prodüss autoanticorp che mira al recetur IgE de alta affinità (FcεRI) in sui mastocit, che porta a la sua attivaziun e al rilasci de istamina e olter mediadur.

In de l'urticaria acuta e cronica, el rilasciament de istamina e olter mediator porta ai sintom carateristich de prurito, ros e gonfior.

El tratament de solet el coinvolge l'uso de antiistaminich per blocar i efet de l'istamina e ridur i sintom.

In di cas sever, pœden vesser drovads olter medegh cuma i corticosteroid o l'omalizumab per controllar la condizion.

['Referenz']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Wahlgren CF: Pathophysiology of itching in urticaria and atopic dermatitis. Allergy. 1992, 47 (2 Pt 1): 65-75.

Raap U, Liekenbröcker T, Wieczorek D, Kapp A, Wedi B: [New therapeutic strategies for the different subtypes of urticaria]. Hautarzt. 2004, 55 (4): 361-6.

[Recommendations for the diagnosis and treatment of urticaria in children]. Arch Argent Pediatr. 2021, 119 (2): S54-S66.

Marrouche N, Grattan C: Childhood urticaria. Curr Opin Allergy Clin Immunol. 2012, 12 (5): 485-90.

Brzoza Z, Grzeszczak W, Rogala B, Trautsolt W, Moczulski D: Possible contribution of chemokine receptor CCR2 and CCR5 polymorphisms in the pathogenesis of chronic spontaneous autoreactive urticaria. Allergol Immunopathol (Madr). , 42 (4): 302-6.

Sweeney TM, Dexter WW: Cholinergic urticaria in a jogger: ruling out exercise-induced anaphylaxis. Phys Sportsmed. 2003, 31 (6): 32-6.

['Disclaimer: medegh']

['Chestu sit web l"è furnid dumà per scopi educatif e informativ e l"è minga un cunsigli medich o un servizzi prufessiunal.']

["I informaziun furnid i g'han minga de vess drovad per diagnosticar o curar un prublema de salute o una malatia, e quei qe i cercan un cunsili medegh personal i g'han de consultar un medegh licenziad."]

['Per piasè, tegnì cont che la red neural che la genera rispost ai dumand l"è minga precisa quand che se tratta de numer, per esempi, el numer de gent che g\'ha una malattia precisa.']

["Cercà semper el cunsili del tò dutur o de un olter fornitur de sanità qualificaa in su una cundizion medica. Mai ignorà el cunsili medich prufessional o ritardà in de cercàll per via de un quaicoss che te gh'heet legiu in su'sto sit web. Se te penset de avègh una emergenza medica, ciama el 911 o va in del pronto soccors püssee vesin subit."]

['Disclaimer: copyright']

["El Digital Millennium Copyright Act del 1998, 17 U.S.C. § 512 (el DMCA) el dà recurs ai proprietari de copyright che creden che el material che 'l compariss in su Internet el infrange i sò dirit sota la legg di copyright di Stat Ünì. "]

["Se te credet de bona fede che un qualcun contegnü o material metüü a disposiziun in cunnessión cun el noster sit web o i noster servizzi infrang el tò copyright, te (o el tò agent) pudet mandà un avisi che dumanda che el contegnü o material vegn tolt, o che l'access a lü el vegn blocaa."]

['I avisi i g\'ha de vess mandaa per scrit per email (varda la sezion "Cuntatt" per l\'indirizz email).']

["La DMCA la dis che la tua notifica de presunta violazion del copyright la gh'ha de cuntà la seguent informazion: (1) descrizion de l'opera protetta dal copyright che l'è oget de la presunta violazion; (2) descrizion del presunt contegnud che 'l viola e informazion suficent per permetem de localizà el contegnud; (3) informazion de contatt per ti, cumprend el to indirizz, numer de telefon e indirizz email; (4) una declarazion de ti che te gh'heet bona fede che 'l contegnud de la manera reclamada l'è minga autorizzaa del proprietari del copyright, o del sò agent, o de la funzion de nissuna legg; "]

['(5) una declaraziun de ti, firmada sota pena de spergiur, che l\'informaziun in de la notificaziun l"è precisa e che te gh\'heet l\'autorità per fà valer i dirit de autor che se pretend de vess violaa;']

['e (6) una firma fisica o eletronica del proprietari del copyright o de una persona autorizada a agì per el proprietari del copyright.']

['Se no se inclüden tücc i infurmaziun sura indicà pœden causà un ritard in del processà la tua denuncia.']

['cuntatt']

['Per piasè mandem una mail cun qual-sa-vöör dumanda/suggeriment.']

What is pathophysiology of urticaria?

Urticaria, commonly known as hives, is a skin condition characterized by the appearance of itchy, raised, red welts (wheals) on the skin.

The pathophysiology of urticaria involves the release of histamine and other inflammatory mediators from mast cells, which are immune cells found in the skin and other tissues.

In acute urticaria, the release of histamine and other mediators is triggered by an allergic reaction to a specific allergen, such as food, medication, or insect sting.

This causes the mast cells to degranulate, releasing histamine and other mediators that cause blood vessels to become leaky, leading to the formation of wheals.

In chronic urticaria, the cause is often unknown, but it is thought to be related to an autoimmune mechanism.

In this case, the body produces autoantibodies that target the high-affinity IgE receptor (FcεRI) on mast cells, leading to their activation and the release of histamine and other mediators.

In both acute and chronic urticaria, the release of histamine and other mediators leads to the characteristic symptoms of itching, redness, and swelling.

Treatment typically involves the use of antihistamines to block the effects of histamine and reduce symptoms.

In severe cases, other medications such as corticosteroids or omalizumab may be used to control the condition.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.